| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC | EVP and Chief Medical Officer | Common Stock | 53.8K | $1.97M | $36.62 | Sep 13, 2024 | Direct |
| BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Medical Officer | Common Stock | 0 | $1.80 | Mar 22, 2022 | Direct | |
| BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Medical Officer | Restricted Stock Units | 0 | Mar 22, 2022 | Direct | ||
| BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Medical Officer | Stock Options (right to buy) | 0 | $2.93 | Mar 22, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Sep 13, 2024 | 1 | -$351K | 4 | Sep 17, 2024 | EVP and Chief Medical Officer |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Feb 29, 2024 | 1 | -$36.6K | 4 | Mar 4, 2024 | EVP and Chief Medical Officer |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Feb 12, 2024 | 4 | -$108K | 4 | Feb 14, 2024 | EVP and Chief Medical Officer |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Feb 10, 2023 | 1 | $0 | 4 | Feb 14, 2023 | EVP and Chief Medical Officer |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | Mar 23, 2022 | 0 | $0 | 3 | Apr 1, 2022 | EVP and Chief Medical Officer |
| BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Mar 22, 2022 | 6 | $0 | 4 | Mar 22, 2022 | Chief Medical Officer |
| BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Jan 27, 2022 | 8 | $949K | 4 | Jan 31, 2022 | Chief Medical Officer |